Literature reviews  >  Articles for review > Niklasson et al. Lactate dehydrogenase and its... 

 

About SDI
Mission
Diagnostic
Priorities
Workplan
Activities
Newsletters
Grants
Publications
Journal articles
Guidelines
Manuals
Reports
Literature reviews
Contact us

Lactate dehydrogenase activity in vaginal fluid is elevated in samples from women with vaginal inflammation.

Lactate dehydrogenase and its isoenzymes in vaginal fluid in vaginitis/vaginosis cases and in healthy controls.
Niklasson O, Skude G, Mårdh P-A
International Journal of STD & AIDS 2003;14:270-273

 

Summary:

Question
What is the lactate dehydrogenase activity, including the isoenzyme pattern, in vaginal fluid samples collected by lavage and by brush, which were stored under different conditions, obtained from women of different ages, presenting with and without signs of vaginitis, vaginosis, and cervicitis?

Design
The total lactate dehydrogenase (LD) activity and the activity of LD isoenzymes 1, 2, 3, 4, and 5 were measured in vaginal lavage and brush samples collected from women with vaginitis/vaginosis and from healthy controls.

Participants
Twenty-eight women, including 8 who were postmenopausal, with no signs of inflammation by vaginal wet mount examination, 8 women with either vulvovaginal candidosis, bacterial vaginosis, trichomoniasis, or senile colpitis, 51 women with various gynecological disorders, and 100 women screened for C. trachomatis who attended for contraceptive counseling were tested. Women whose wet mount contained spermatozoa were excluded from further analyses.

Description of Tests and Diagnostic Standard
Fluid samples were collected from the posterior vaginal fornix with a brush (Cytobrush, Medscand, Sweden) or by instilling 5 ml of saline and aspirating the fluid into a syringe. Both samples were placed into 5 ml of Tris buffer, centrifuged, and the supernatants used for determination of LD activity within a few minutes of collection and after storage at room temperature and at 4oC for 6 h. The tip of the vaginal speculum inserted for the pelvic examination was used to measure pH and to prepare a wet mount. Vaginal inflammation was measured by determining the number of granulocytes in wet mounts. Leukocyte esterase in vaginal samples was measured using a dipstick (Combur-4, Roche Diagnostics, Basel). Chlamydiazyme ELISA (Abbott Diagnostics, Chicago) was used to detect chlamydial infections. Positive results were confirmed.

Main Outcome Measures
The influence of different sample collection and storage conditions on LD activity was evaluated. LD activity (μkat/L) was correlated to vaginal pH, the grade of inflammation as determined by the number of granulocytes in a wet mount, C. trachomatis infection, leukocyte esterase activity, and vaginitis.

Main Results
There were no differences in the amount of LD measured in lavage samples compared to brush samples, in samples analyzed immediately compared to after 6 h, or in samples stored at room temperature compared to refrigerated. In women with no signs of genital inflammation, the total LD activity was low (<3.0 μkat/L) and the isoenzyme pattern was dominated by LD5. Most women with inflammation on wet mount (>10 granulocytes/high power field) had higher LD activity and vaginal pH than women with no or mild inflammation. Vaginal LD activity increased with increasing pH and was high in women positive for C. trachomatis. All patients with an elevated leukocyte esterase result (grade 3) had increased LD activity. The total LD and LD isoenzyme activities in vaginal lavage fluid samples from normal controls and from women with vaginitis/vaginosis are shown in the table.

Authors' Conclusions
Determination of the total concentration of LD was sensitive enough to discriminate cases with genital inflammation from healthy individuals. The more intense the inflammation, the higher was the LD activity. Analysis of individual isoenzymes was not necessary.

Source of funding: None given.

For correspondence: Per-Andres Mårdh, Department of Obstetrics and Gynecology, Lund University Hospital, 22185 Lund. E-mail address: per-anders.mardh@gyn.lu.se

   

about SDI | newsletters | grants | publications | literature reviews

WHO Home - WHO Search - TDR Home - SDI Home - SDI Contact us
(c) WHO/OMS 2001